MedTrace Logo

Long-term Oxygen Treatment (LTOT) in Chronic Obstructive Pulmonary Disease: Factors Influencing Survival

NCT00871962 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2015-06-23

No results posted yet for this study

Summary

The purpose of this prospective cohort study is to determine factors involved in survival in new COPD patients treated by long-term oxygen therapy.

Background: long-term oxygen therapy is indicated in patients with severe COPD. No studies have been performed in the past 20-25 years to examine the results of early clinical trials. Further studies are necessary to understand the utility of oxygen therapy in severe COPD.

Conditions

Interventions

OTHER

OXYGEN SUPPLEMENTATION

Patients treated by LTOT, with or without clinically fulfilled criteria for LTOT, with PaO2\<55mmHg or less at rest or during sleeping or less during exercise, if supplemental oxygen is demonstrated to improve the exercise-associated hypoxia. Patients with PaO2 56-59mmHg if they also have dependent edema, pulmonary hypertension or hematocrit higher than 56%

Sponsors & Collaborators

  • Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche

    lead OTHER

Principal Investigators

  • MELLONI Boris, Pr · Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2015-12-31
Completion
2016-05-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00871962 on ClinicalTrials.gov